Nexeon MedSystems Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Nexeon MedSystems Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011412
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nexeon MedSystems Inc (Nexeon) is a bioelectronics company that develops and commercializes therapies and devices for the treatment of cardiovascular diseases. The company’s products categories include nanotechnology-based devices, embolic protection systems, local drug and biologic delivery systems, and cell delivery and regenerative therapy devices in various stages of development. It develops anatomy-specific combination embolic protection and stent delivery systems for endovascular procedures. The company develops cell delivery and regenerative therapies for delivery of stem cells and biologics to target end-organ sites in order to treat conditions such as chronic congestive heart failure, chronic critical limb ischemia and acute myocardial infarction. Nexeon is headquartered in Dallas, Texas, the US.

Nexeon MedSystems Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nexeon MedSystems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Nexeon MedSystems Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Nexeon MedSystems Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Nexeon MedSystems Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Nexeon MedSystems Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Nexeon MedSystems Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Nexeon MedSystems Raises USD0.1 Million in Venture Financing 10
Nexeon Medsystems Raises Private Round of Funding 11
Nexeon MedSystems Raises USD1.3 Million in Financing 12
Partnerships 13
Nexeon MedSystems Enters into Licensing Agreement with William Rosellini 13
Equity Offering 14
Nexeon MedSystems to Raise Funds in Private Placement of Shares 14
Acquisition 15
Nexeon MedSystems Acquires Nexeon Medsystems Belgium from Rosellini Scientific 15
Nexeon Medsystems Belgium Acquires Medi-Line 16
Nexeon MedSystems Inc – Key Competitors 17
Nexeon MedSystems Inc – Key Employees 18
Nexeon MedSystems Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Legal and Regulatory 20
Sep 28, 2017: Nexeon MedSystems Begins Trading as NXNN 20
Other Significant Developments 21
Aug 08, 2017: Nexeon Receives Research Grant from National Institutes of Health 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Nexeon MedSystems Inc, Medical Equipment, Key Facts 2
Nexeon MedSystems Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Nexeon MedSystems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Nexeon MedSystems Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Nexeon MedSystems Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Nexeon MedSystems Inc, Deals By Market, 2011 to YTD 2017 8
Nexeon MedSystems Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Nexeon MedSystems Raises USD0.1 Million in Venture Financing 10
Nexeon Medsystems Raises Private Round of Funding 11
Nexeon MedSystems Raises USD1.3 Million in Financing 12
Nexeon MedSystems Enters into Licensing Agreement with William Rosellini 13
Nexeon MedSystems to Raise Funds in Private Placement of Shares 14
Nexeon MedSystems Acquires Nexeon Medsystems Belgium from Rosellini Scientific 15
Nexeon Medsystems Belgium Acquires Medi-Line 16
Nexeon MedSystems Inc, Key Competitors 17
Nexeon MedSystems Inc, Key Employees 18
Nexeon MedSystems Inc, Subsidiaries 19

★海外企業調査レポート[Nexeon MedSystems Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kotra Industries Berhad (KOTRA):企業の財務・戦略的SWOT分析
    Kotra Industries Berhad (KOTRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • BOC Aviation Limited (2588):企業の財務・戦略的SWOT分析
    BOC Aviation Limited (2588) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Ipsen Biopharmaceuticals Inc:企業の戦略的SWOT分析
    Ipsen Biopharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Cabela’s Incorporated:企業の戦略・SWOT・財務情報
    Cabela's Incorporated - Strategy, SWOT and Corporate Finance Report Summary Cabela's Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Just Energy Group Inc. (JE):企業の財務・戦略的SWOT分析
    Just Energy Group Inc. (JE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Irving Oil Ltd:企業の戦略的SWOT分析
    Irving Oil Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Thales SA:企業の戦略・SWOT・財務情報
    Thales SA - Strategy, SWOT and Corporate Finance Report Summary Thales SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Canon Marketing Japan Inc (8060):企業の財務・戦略的SWOT分析
    Canon Marketing Japan Inc (8060) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Mangalam Drugs and Organics Ltd (MANGALAM):企業の財務・戦略的SWOT分析
    Summary Mangalam Drugs and Organics Ltd (MDOL) is a chemical manufacturing company that manufactures, develops, and supplies specialty chemicals, intermediates, and active pharmaceutical ingredients. The company's active pharmaceutical ingredients include amodiaquine HCl, bisoprolol fumarate, chloro …
  • ALPCO Diagnostics:医療機器:M&Aディール及び事業提携情報
    Summary ALPCO Diagnostics (ALPCO) is a life science company that imports and distributes immunoassay based products. The company offers immunoassays, chemiluminescent assays, flow cytometry reagents, purified antibodies, recombinant proteins, and HPLC and MS-MS reagents. It provides food additives, …
  • Australia and New Zealand Banking Group Ltd:企業のM&A・事業提携・投資動向
    Australia and New Zealand Banking Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Australia and New Zealand Banking Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • The Heavitree Brewery PLC:企業の戦略・SWOT・財務情報
    The Heavitree Brewery PLC - Strategy, SWOT and Corporate Finance Report Summary The Heavitree Brewery PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • ContextVision AB (COV):企業の財務・戦略的SWOT分析
    Summary ContextVision AB (ContextVision) is a medical technology company that specializes in image analysis and artificial intelligence software solutions. The company develops image enhancement software solutions for magnetic resonance imaging, digital pathology, ultrasound, X-ray, fluoroscopy, mam …
  • Exosome Diagnostics Inc:企業の製品パイプライン分析
    Summary Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics’ services comprise miRNA profiling, mRNA p …
  • Coeur Mining, Inc:企業のM&A・事業提携・投資動向
    Coeur Mining, Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Coeur Mining, Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Beneo GmbH:企業の戦略・SWOT・財務分析
    Beneo GmbH - Strategy, SWOT and Corporate Finance Report Summary Beneo GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • KDDI Corporation:戦略・SWOT・企業財務分析
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • PledPharma AB (PLED):企業の財務・戦略的SWOT分析
    Summary PledPharma AB (PledPharma) is a pharmaceutical company that discovers, manufactures, and develops drugs that protect the body against oxidative stress. The company discovers and develops Aladote and PledOx drugs. Its PledOX drug is used to prevent chemotherapy-induced side effects for colore …
  • KUBOTA Corporation:企業の戦略・SWOT・財務情報
    KUBOTA Corporation - Strategy, SWOT and Corporate Finance Report Summary KUBOTA Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • AroCell AB (AROC):製薬・医療:M&Aディール及び事業提携情報
    Summary AroCell AB (AroCell), formerly Xi Bao Research AB, is a drug development company that develops and commercializes tests used for the prognosis and monitoring of treatment of cancer. The company develops TK 210 ELISA kits for measuring the enzyme TK1 which is a protein that is elevated in the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆